Martin Rudwaleit

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 35

Top Venues

RMD open

Annals of the rheumatic diseases

Radiology

Zeitschrift fur Rheumatologie

Klinikum Bielefeld

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Klinikum Bielefeld

Germany

Head :: Internal Medicine and Rheumatology

Publications

Xenofon Baraliakos, Pedro M Machado, Lars Bauer, Bengt Hoepken, Mindy Kim, Thomas Kumke, Rachel Tham, Martin Rudwaleit
Comparison of established and preliminarily proposed ASAS MRI working group cut-offs for inflammatory MRI lesions in the sacroiliac joints in radiographic and non-radiographic axial spondyloarthritis. RMD open 10 (3) (2024)
Victoria Navarro-Compán, Josef S Smolen, Atul Deodhar, Phillip J Mease, Martin Rudwaleit, Christine de la Loge, Carmen Fleurinck, Vanessa Taieb, Michael F Mørup, Ute Massow, Jonathan Kay, Marina Magrey
Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2. RMD open 10 (2) (2024)
Martin Rudwaleit, Atul Deodhar, Lars Bauer, Lianne Gensler, Bengt Hoepken, Thomas Kumke, Simone Emanuele Auteri, Mindy Kim, Walter P Maksymowych
Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status. RMD open 10 (2) (2024)
Martin Rudwaleit, Helena Marzo-Ortega, Victoria Navarro-Compán, Rachel Tham, Thomas Kumke, Lars Bauer, Natasha de Peyrecave, Mindy Kim, Filip Van den Bosch
Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis. RMD open 10 (3) (2024)
Maureen Dubreuil, Victoria Navarro-Compán, Annelies Boonen, Karl Gaffney, Lianne S Gensler, Christine de la Loge, Thomas Vaux, Carmen Fleurinck, Ute Massow, Vanessa Taieb, Michael F Mørup, Atul Deodhar, Martin Rudwaleit
Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies. RMD open 10 (2) (2024)
Victoria Navarro-Compán, Josef S Smolen, Atul Deodhar, Phillip J Mease, Martin Rudwaleit, Christine de la Loge, Carmen Fleurinck, Vanessa Taieb, Michael F Mørup, Ute Massow, Jonathan Kay, Marina Magrey
Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2. RMD open 10 (2) (2024)
Matthew A Brown, Martin Rudwaleit, Floris A van Gaalen, Nigil Haroon, Lianne S Gensler, Carmen Fleurinck, Alexander Marten, Ute Massow, Natasha de Peyrecave, Thomas Vaux, Katy White, Atul A Deodhar, Irene van der Horst-Bruinsma
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials. Annals of the rheumatic diseases (2024)
Martin Rudwaleit, Atul Deodhar, Lars Bauer, Lianne Gensler, Bengt Hoepken, Thomas Kumke, Simone Emanuele Auteri, Mindy Kim, Walter P Maksymowych
Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status. RMD open 10 (2) (2024)
Maureen Dubreuil, Victoria Navarro-Compán, Annelies Boonen, Karl Gaffney, Lianne S Gensler, Christine de la Loge, Thomas Vaux, Carmen Fleurinck, Ute Massow, Vanessa Taieb, Michael F Mørup, Atul Deodhar, Martin Rudwaleit
Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies. RMD open 10 (2) (2024)
Victoria Navarro-Compán, Josef S Smolen, Atul Deodhar, Phillip J Mease, Martin Rudwaleit, Christine de la Loge, Carmen Fleurinck, Vanessa Taieb, Michael F Mørup, Ute Massow, Jonathan Kay, Marina Magrey
Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2. RMD open 10 (2) (2024)
Jüergen Braun, Elisabeth Märker-Hermann, Martin Rudwaleit, Joachim Sieper
HLA-B27 and the role of specific T cell receptors in the pathogenesis of spondyloarthritis. Annals of the rheumatic diseases (2024)
Victoria Navarro-Compán, Josef S Smolen, Atul Deodhar, Phillip J Mease, Martin Rudwaleit, Christine de la Loge, Carmen Fleurinck, Vanessa Taieb, Michael F Mørup, Ute Massow, Jonathan Kay, Marina Magrey
Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2. RMD open 10 (2) (2024)
Torsten Diekhoff, Iris Eshed, Chiara Giraudo, Hildrun Haibel, Kay-Geert A Hermann, Manouk de Hooge, Lennart B O Jans, Anne Grethe Jurik, Robert G W Lambert, Pedro M Machado, Michael Mallinson, Walter P Maksymowych, Helena Marzo-Ortega, Victoria Navarro-Compán, Mikkel Østergaard, Susanne J Pedersen, Monique Reijnierse, Martin Rudwaleit, Fernando Andrés Sommerfleck, Ulrich Weber, Xenofon Baraliakos, Denis Poddubnyy
Reporting Sacroiliac Joint Imaging Performed for Known or Suspected Axial Spondyloarthritis: Assessment of SpondyloArthritis International Society Recommendations. Radiology 311 (3) (2024)
Martin Rudwaleit, Helena Marzo-Ortega, Victoria Navarro-Compán, Rachel Tham, Thomas Kumke, Lars Bauer, Natasha de Peyrecave, Mindy Kim, Filip Van den Bosch
Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis. RMD open 10 (3) (2024)
Matthew A Brown, Martin Rudwaleit, Floris A van Gaalen, Nigil Haroon, Lianne S Gensler, Carmen Fleurinck, Alexander Marten, Ute Massow, Natasha de Peyrecave, Thomas Vaux, Katy White, Atul A Deodhar, Irene van der Horst-Bruinsma
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials. Annals of the rheumatic diseases (2024)
Martin Rudwaleit, Atul Deodhar, Lars Bauer, Lianne Gensler, Bengt Hoepken, Thomas Kumke, Simone Emanuele Auteri, Mindy Kim, Walter P Maksymowych
Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status. RMD open 10 (2) (2024)
Maureen Dubreuil, Victoria Navarro-Compán, Annelies Boonen, Karl Gaffney, Lianne S Gensler, Christine de la Loge, Thomas Vaux, Carmen Fleurinck, Ute Massow, Vanessa Taieb, Michael F Mørup, Atul Deodhar, Martin Rudwaleit
Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies. RMD open 10 (2) (2024)
Victoria Navarro-Compán, Josef S Smolen, Atul Deodhar, Phillip J Mease, Martin Rudwaleit, Christine de la Loge, Carmen Fleurinck, Vanessa Taieb, Michael F Mørup, Ute Massow, Jonathan Kay, Marina Magrey
Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2. RMD open 10 (2) (2024)
Maureen Dubreuil, Victoria Navarro-Compán, Annelies Boonen, Karl Gaffney, Lianne S Gensler, Christine de la Loge, Thomas Vaux, Carmen Fleurinck, Ute Massow, Vanessa Taieb, Michael F Mørup, Atul Deodhar, Martin Rudwaleit
Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies. RMD open 10 (2) (2024)
Martin Rudwaleit, Atul Deodhar, Lars Bauer, Lianne Gensler, Bengt Hoepken, Thomas Kumke, Simone Emanuele Auteri, Mindy Kim, Walter P Maksymowych
Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status. RMD open 10 (2) (2024)
Torsten Diekhoff, Iris Eshed, Chiara Giraudo, Hildrun Haibel, Kay-Geert A Hermann, Manouk de Hooge, Lennart B O Jans, Anne Grethe Jurik, Robert G W Lambert, Pedro M Machado, Michael Mallinson, Walter P Maksymowych, Helena Marzo-Ortega, Victoria Navarro-Compán, Mikkel Østergaard, Susanne J Pedersen, Monique Reijnierse, Martin Rudwaleit, Fernando Andrés Sommerfleck, Ulrich Weber, Xenofon Baraliakos, Denis Poddubnyy
Reporting Sacroiliac Joint Imaging Performed for Known or Suspected Axial Spondyloarthritis: Assessment of SpondyloArthritis International Society Recommendations. Radiology 311 (3) (2024)
Désirée Mfm van der Heijde, Atul A Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip E Van den Bosch, Thomas Vaux, Huji Xu
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the rheumatic diseases (2023)
Désirée Mfm van der Heijde, Anna Moltó, Josef S Smolen, Jüergen Braun, Maxime Dougados, Floris A van Gaalen, Lianne S Gensler, Robert Davies Inman, Robert B M Landewe, Helena Marzo-Ortega, Victoria Navarro-Compán, Andri Phoka, Denis Poddubnyy, Mikhail Protopopov, John D Reveille, Martin Rudwaleit, Percival Sampaio-Barros, Alexandre Sepriano, Joachim Sieper, Filip E Van den Bosch, Irene van der Horst-Bruinsma, Pedro M Machado, Xenofon Baraliakos
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature. Annals of the rheumatic diseases (2023)
Désirée Mfm van der Heijde, Atul A Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip E Van den Bosch, Thomas Vaux, Huji Xu
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the rheumatic diseases (2023)
Marvin-Hendrik Röchter, Martin Rudwaleit
[Phenomenon of the last meadow]. Zeitschrift fur Rheumatologie (2023)
Martin Rudwaleit, Michael F Mørup, Brittany Humphries, Noor-E Zannat, Damon Willems, Vanessa Taieb, Annelies Boonen
Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis. RMD open 9 (4) (2023)
Victoria Navarro-Compán, Diego Benavent, Dafne Capelusnik, Désirée Mfm van der Heijde, Robert B M Landewe, Denis Poddubnyy, Astrid van Tubergen, Xenofon Baraliakos, Filip E Van den Bosch, Floris A van Gaalen, Lianne S Gensler, Clementina López Medina, Helena Marzo-Ortega, Anna Moltó, Rodolfo Pérez-Alamino, Martin Rudwaleit, Marleen van de Sande, Alice Heaney, Ulrich Weber, Josef S Smolen
ASAS consensus definition of early axial spondyloarthritis. Annals of the rheumatic diseases (2023)
Désirée Mfm van der Heijde, Lianne S Gensler, Walter P Maksymowych, Robert B M Landewe, Martin Rudwaleit, Lars Bauer, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri, Bengt Hoepken, Atul A Deodhar
Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study. RMD open 8 (1) (2022)
Murat Torğutalp, Valeria Rios Rodriguez, Ani Dilbaryan, Fabian Proft, Mikhail Protopopov, Maryna Verba, Judith Rademacher, Hildrun Haibel, Joachim Sieper, Martin Rudwaleit, Denis Poddubnyy
Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis. Annals of the rheumatic diseases (2022)
Josef S Smolen, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, Robert B M Landewe, Filip E Van den Bosch, Boryana Boteva, Ann Bremander, Philippe Carron, Adrian Ciurea, Floris A van Gaalen, Pál Géher, Lianne Gensler, Josef Hermann, Manouk de Hooge, Marketa Husakova, Uta Kiltz, Clementina López Medina, Pedro M Machado, Helena Marzo-Ortega, Anna Moltó, Victoria Navarro-Compán, Michael John Nissen, Fernando M Pimentel-Santos, Denis Poddubnyy, Fabian Proft, Martin Rudwaleit, Mark Telkman, Sizheng Steven Zhao, Nelly Ziadé, Désirée Mfm van der Heijde
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Annals of the rheumatic diseases (2022)
Xenofon Baraliakos, Mikkel Østergaard, Robert Gw Lambert, Iris Eshed, Pedro M Machado, Susanne Juhl Pedersen, Ulrich Weber, Manouk de Hooge, Joachim Sieper, Denis Poddubnyy, Martin Rudwaleit, Désirée Mfm van der Heijde, Robert B M Landewe, Walter P Maksymowych
MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group. Annals of the rheumatic diseases (2022)
Berthold Hoppe, Christian Schwedler, Hildrun Haibel, Maryna Verba, Fabian Proft, Mikhail Protopopov, Hans-Gert Heuft, Valeria Rios Rodriguez, Anke Edelmann, Martin Rudwaleit, Joachim Sieper, Denis Poddubnyy
Predictive value of C-reactive protein for radiographic spinal progression in axial spondyloarthritis in dependence on genetic determinants of fibrin clot formation and fibrinolysis. RMD open 7 (2) (2021)
Irene van der Horst-Bruinsma, Rianne van Bentum, Frank D Verbraak, Thomas Rath, James T Rosenbaum, Maria Misterska-Skora, Bengt Hoepken, Oscar Irvin-Sellers, Brenda VanLunen, Lars Bauer, Martin Rudwaleit
The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW. RMD open 6 (1) (2021)
Walter P Maksymowych, Susanne Juhl Pedersen, Ulrich Weber, Xenofon Baraliakos, Pedro M Machado, Iris Eshed, Manouk de Hooge, Joachim Sieper, Stephanie Wichuk, Martin Rudwaleit, Désirée Mfm van der Heijde, Robert B M Landewé, Denis Poddubnyy, Mikkel Ostergaard, Robert G W Lambert
Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort: discrepancies with local readers and impact on the performance of the ASAS criteria. Annals of the rheumatic diseases 79 (7) (2020)
Martin Rudwaleit
Involvement of industry in review articles published in Annals of the Rheumatic Diseases. Annals of the rheumatic diseases 80 (11) (2019)

Martin Rudwaleit.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Martin Rudwaleit